Methods for treatment of diseases associated with inflammation under nonischemic conditions

Details for Australian Patent Application No. 2001254626 (hide)

Owner Action Pharma A/S

Inventors Frokiaer, Jorgen; Bjerke, Thorbjorn; Nielsen, Soren; Jonassen, Thomas Engelbrecht Norkild

Agent FB Rice

Pub. Number AU-B-2001254626

PCT Pub. Number WO01/82953

Priority 60/201,264 02.05.00 US; PA200001204 11.08.00 DK; PA200100369 06.03.01 DK; PA200001757 22.11.00 DK

Filing date 2 May 2001

Wipo publication date 12 November 2001

Acceptance publication date 21 September 2006

International Classifications

A61K 38/34 (2006.01) Medicinal preparations containing peptides

A61K 38/13 (2006.01) Medicinal preparations containing peptides

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

Event Publications

17 November 2005 Change of Name(s) of Applicant(s), Section 104

  Action Pharma APS The name of the applicant has been changed to Action Pharma A/S 2003

24 November 2005 Assignment before Grant

  Selskabet af 20.02.2002 ApS The application has been assigned to Action Pharma A/S

21 September 2006 Application Accepted

  Published as AU-B-2001254626

18 January 2007 Standard Patent Sealed

27 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001254627

2001254625-Use of alpha-MSH and EPO for preventing or treating ischemic conditions